takeda-ibdsymposium.net
Floor plan | New Horizons in IBD therapy at UEG Week 2014, Vienna
http://www.takeda-ibdsymposium.net/floor-plan
Learn more about the science of IBD at: http:/ ibdinsights.net. Organised and funded by Takeda Pharmaceuticals International GmbH. Date of preparation: October 2014 - Job number: GLO/EYV/2014-00010. This website uses cookies for anonymous metrics only.
takeda-ibdsymposium.net
Agenda | New Horizons in IBD therapy at UEG Week 2014, Vienna
http://www.takeda-ibdsymposium.net/agenda
Chairman’s introduction: Opportunities for clinical success. Herbert Tilg Innsbruck, Austria. Therapeutic approaches in IBD and treatment goals. Stefan Schreiber Kiel, Germany. New treatment options in IBD: today and the future. Silvio Danese Milan, Italy. Panel discussion: Treatment decision-making in clinical practice. Geert D’Haens Amsterdam, Netherlands. Learn more about the science of IBD at: http:/ ibdinsights.net. Organised and funded by Takeda Pharmaceuticals International GmbH.
takeda-ibdsymposium.net
Biographies | New Horizons in IBD therapy at UEG Week 2014, Vienna
http://www.takeda-ibdsymposium.net/biographies
Herbert Tilg is Professor of Internal Medicine and Director of the Division of Endocrinology, Gastroenterology and Metabolism at Innsbruck Medical University, Austria. Professor Tilg’s research interests include mechanisms of chronic inflammation, cytokine and adipocytokine research, intestinal immunity, and metabolic inflammation. He has published over 150 original articles and 50 invited reviews in peer-reviewed journals, and is a member of the Editorial Board for Gut. Dr Silvio Danese, MD, PhD is Dire...
takeda-ibdsymposium.net
Key slides | New Horizons in IBD therapy at UEG Week 2014, Vienna
http://www.takeda-ibdsymposium.net/key-slides
Learn more about the science of IBD at: http:/ ibdinsights.net. Organised and funded by Takeda Pharmaceuticals International GmbH. Date of preparation: October 2014 - Job number: GLO/EYV/2014-00010. This website uses cookies for anonymous metrics only.
takeda-ibdsymposium.net
Abstracts | New Horizons in IBD therapy at UEG Week 2014, Vienna
http://www.takeda-ibdsymposium.net/abstracts
Chairman’s introduction: opportunities for clinical success. Inflammatory bowel disease (IBD) has a complex pathophysiology and diverse clinical presentation. Optimising treatment is critical in order to achieve the best results for patients. Initiating biologic therapy earlier on in the disease course has been associated with higher remission rates in patients with Crohn’s disease. Through recognising and addressing unmet needs in IBD care, there are opportunities for us to improve clinical practice and...
takedaibd.com
Takeda IBD
http://www.takedaibd.com/page1.html
Explore our archive of previous events. Choose one of these Takeda-organised IBD symposia. Learn more about the science of IBD at www.ibdinsights.net. Adverse events should be reported to the authorities in your country as required by local law. Adverse events should also be reported to Takeda at eupv@tgrd.com. This website is organised and funded by Takeda Pharmaceuticals International AG. This website is the property of Takeda Pharmaceuticals International AG. Date of preparation: January 2017.
